These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16513230

  • 1. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
    Fathallah H, Atweh GF.
    Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
    [Abstract] [Full Text] [Related]

  • 2. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.
    Testa U.
    Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856
    [Abstract] [Full Text] [Related]

  • 3. Disorders of the synthesis of human fetal hemoglobin.
    Manca L, Masala B.
    IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic induction of fetal hemoglobin production.
    Atweh G, Fathallah H.
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1131-44. PubMed ID: 21075284
    [Abstract] [Full Text] [Related]

  • 5. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, Castro O, Barton F.
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [Abstract] [Full Text] [Related]

  • 6. Cellular genomic reporter assays for screening and evaluation of inducers of fetal hemoglobin.
    Vadolas J, Wardan H, Orford M, Williamson R, Ioannou PA.
    Hum Mol Genet; 2004 Jan 15; 13(2):223-33. PubMed ID: 14645208
    [Abstract] [Full Text] [Related]

  • 7. Modifier genes in Mendelian disorders: the example of hemoglobin disorders.
    Sankaran VG, Lettre G, Orkin SH, Hirschhorn JN.
    Ann N Y Acad Sci; 2010 Dec 15; 1214():47-56. PubMed ID: 21039591
    [Abstract] [Full Text] [Related]

  • 8. Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.
    Saunthararajah Y, DeSimone J.
    Semin Hematol; 2004 Oct 15; 41(4 Suppl 6):11-6. PubMed ID: 15534852
    [Abstract] [Full Text] [Related]

  • 9. In vivo and in vitro studies of fetal hemoglobin induction by hydroxyurea in beta-thalassemia/hemoglobin E patients.
    Watanapokasin Y, Chuncharunee S, Sanmund D, Kongnium W, Winichagoon P, Rodgers GP, Fucharoen S.
    Exp Hematol; 2005 Dec 15; 33(12):1486-92. PubMed ID: 16338491
    [Abstract] [Full Text] [Related]

  • 10. Induction of fetal hemoglobin in the treatment of sickle cell disease.
    Fathallah H, Atweh GF.
    Hematology Am Soc Hematol Educ Program; 2006 Dec 15; ():58-62. PubMed ID: 17124041
    [Abstract] [Full Text] [Related]

  • 11. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R, Sanmund D, Winichagoon P, Muta K, Fucharoen S.
    Ann Hematol; 2006 Mar 15; 85(3):164-9. PubMed ID: 16389564
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
    Stamatoyannopoulos JA, Nienhuis AW.
    Annu Rev Med; 1992 Mar 15; 43():497-521. PubMed ID: 1374600
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Mar 15; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ, Humphries RK, Young N, Ley T, Boyer S, Charache S, Nienhuis A.
    Prog Clin Biol Res; 1985 Mar 15; 191():447-54. PubMed ID: 2413480
    [Abstract] [Full Text] [Related]

  • 15. Fetal globin induction in beta-thalassemia.
    El-Beshlawy A, Hamdy M, El Ghamrawy M.
    Hemoglobin; 2009 Mar 15; 33 Suppl 1():S197-203. PubMed ID: 20001626
    [Abstract] [Full Text] [Related]

  • 16. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
    Kan YW.
    Schweiz Med Wochenschr Suppl; 1991 Mar 15; 43():51-4. PubMed ID: 1726857
    [Abstract] [Full Text] [Related]

  • 17. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
    Borg J, Phylactides M, Bartsakoulia M, Tafrali C, Lederer C, Felice AE, Papachatzopoulou A, Kourakli A, Stavrou EF, Christou S, Hou J, Karkabouna S, Lappa-Manakou C, Ozgur Z, van Ijcken W, von Lindern M, Grosveld FG, Georgitsi M, Kleanthous M, Philipsen S, Patrinos GP.
    Pharmacogenomics; 2012 Oct 15; 13(13):1487-500. PubMed ID: 23057549
    [Abstract] [Full Text] [Related]

  • 18. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ, Nienhuis AW.
    Annu Rev Med; 1985 Oct 15; 36():485-98. PubMed ID: 2581500
    [Abstract] [Full Text] [Related]

  • 19. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
    Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC.
    Haematologica; 2004 Oct 15; 89(10):1172-8. PubMed ID: 15477200
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H, Sutton M, Atweh GF.
    Ann N Y Acad Sci; 2005 Oct 15; 1054():228-37. PubMed ID: 16339670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.